Tech Company Inital Public Offerings
Cidara Therapeutics IPO
Cidara Therapeutics, operating out of San Diego, debuted as a public company on 4/15/2015.
Transaction Overview
Company Name
Announced On
4/15/2015
Transaction Type
IPO
Amount
$76,800,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
6310 Nancy Ridge Dr. 101
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Cidara is focused on developing novel anti-infectives to address serious infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Stein
Chief Medical Officer
Taylor Sandison
Chief Operating Officer
Paul Daruwala
VP - Bus. Development
Neil Abdollahian
VP - Operations
Laura Navalta
VP - R & D
Les Tari
VP - Regulatory Affairs
Carmen Betancourt
Browse more venture capital transactions:
Prev: 4/15/2015: Benchling venture capital transaction
Next: 4/15/2015: Wrap venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs